Regeneron slides after melanoma study misses key endpoint (REGN)

Stocks Yahoo Finance By Yahoo Finance 18 May 2026 10:19 1 min read

Regeneron slides after melanoma study misses key endpoint (REGN)

Regeneron slides after melanoma study misses key endpoint (REGN)

Regeneron slides after melanoma study misses key endpoint (REGN)

Read the full story on Yahoo Finance → Opens the original article on finance.yahoo.com

Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.